Mid Atlantic Bio Angels (MABA) is a NY-based life science angel investor group, formed in 2012, that invests exclusively in life science science companies, with no geographic limitations.

  • Because of MABA’s life science focus, the majority of our members are active in the industry:

    • Several MABA members are MDs, most of whom are practicing physicians
    • Many members are either currently working for, or in the past have worked for a pharmaceutical, biotech or medical device company
    • Many members either currently, or in the past, have held C level positions, and many are founders of companies in the life science space
    • Several members are attorneys
    • Multiple members founded, hold or have held senior positions in private equity, venture capital and hedge funds, while several hold/held CFO positions
    • Multiple specialties are featured among the members, including many medical specialties, such as radiation oncology, ophthalmology, toxicology, regulatory (with some members having worked at the FDA), as well as non-medical specialties, such as marketing, finance (several MBAs) and engineering
    • Several pharmaceutical and device companies have also joined MABA as members
  • MABA’s individual members are accredited and active investors with specific interest in life science investments

  • MABA meetings are held monthly in NYC, with the exception of summer months

  • MABA investments include individual investments, member-only Pools and a Sidecar Fund – for non-MABA members, that co-invests and essentially indexes the active membership’s investments

  • MABA individuals/Pools/Sidecar Fund typically invest between $250,000 and $1 million per round, in early rounds, and participate in follow-on rounds

  • MABA typically invests in 2% of the applications it receives